S&P 500   3,851.18 (-0.11%)
DOW   30,948.17 (-0.04%)
QQQ   328.76 (+0.20%)
AAPL   142.35 (-0.40%)
MSFT   232.47 (+1.28%)
FB   283.01 (+1.80%)
GOOGL   1,901.40 (+0.38%)
AMZN   3,322.10 (+0.85%)
TSLA   888.76 (+0.90%)
NVDA   540.58 (-1.02%)
BABA   262.60 (+0.47%)
CGC   35.20 (+6.96%)
GE   11.21 (+2.00%)
MU   80.70 (-0.71%)
AMD   95.19 (+1.13%)
NIO   59.97 (-0.03%)
T   29.40 (+1.00%)
F   11.17 (-1.06%)
ACB   10.64 (+4.72%)
BA   202.93 (-0.21%)
DIS   170.50 (-0.81%)
NFLX   566.59 (+1.76%)
GILD   66.87 (-1.89%)
S&P 500   3,851.18 (-0.11%)
DOW   30,948.17 (-0.04%)
QQQ   328.76 (+0.20%)
AAPL   142.35 (-0.40%)
MSFT   232.47 (+1.28%)
FB   283.01 (+1.80%)
GOOGL   1,901.40 (+0.38%)
AMZN   3,322.10 (+0.85%)
TSLA   888.76 (+0.90%)
NVDA   540.58 (-1.02%)
BABA   262.60 (+0.47%)
CGC   35.20 (+6.96%)
GE   11.21 (+2.00%)
MU   80.70 (-0.71%)
AMD   95.19 (+1.13%)
NIO   59.97 (-0.03%)
T   29.40 (+1.00%)
F   11.17 (-1.06%)
ACB   10.64 (+4.72%)
BA   202.93 (-0.21%)
DIS   170.50 (-0.81%)
NFLX   566.59 (+1.76%)
GILD   66.87 (-1.89%)
S&P 500   3,851.18 (-0.11%)
DOW   30,948.17 (-0.04%)
QQQ   328.76 (+0.20%)
AAPL   142.35 (-0.40%)
MSFT   232.47 (+1.28%)
FB   283.01 (+1.80%)
GOOGL   1,901.40 (+0.38%)
AMZN   3,322.10 (+0.85%)
TSLA   888.76 (+0.90%)
NVDA   540.58 (-1.02%)
BABA   262.60 (+0.47%)
CGC   35.20 (+6.96%)
GE   11.21 (+2.00%)
MU   80.70 (-0.71%)
AMD   95.19 (+1.13%)
NIO   59.97 (-0.03%)
T   29.40 (+1.00%)
F   11.17 (-1.06%)
ACB   10.64 (+4.72%)
BA   202.93 (-0.21%)
DIS   170.50 (-0.81%)
NFLX   566.59 (+1.76%)
GILD   66.87 (-1.89%)
S&P 500   3,851.18 (-0.11%)
DOW   30,948.17 (-0.04%)
QQQ   328.76 (+0.20%)
AAPL   142.35 (-0.40%)
MSFT   232.47 (+1.28%)
FB   283.01 (+1.80%)
GOOGL   1,901.40 (+0.38%)
AMZN   3,322.10 (+0.85%)
TSLA   888.76 (+0.90%)
NVDA   540.58 (-1.02%)
BABA   262.60 (+0.47%)
CGC   35.20 (+6.96%)
GE   11.21 (+2.00%)
MU   80.70 (-0.71%)
AMD   95.19 (+1.13%)
NIO   59.97 (-0.03%)
T   29.40 (+1.00%)
F   11.17 (-1.06%)
ACB   10.64 (+4.72%)
BA   202.93 (-0.21%)
DIS   170.50 (-0.81%)
NFLX   566.59 (+1.76%)
GILD   66.87 (-1.89%)
Log in

2020 Election Stock Market Forecast

Below you will find a list of companies that have had the highest percentage gains and losses since the U.S. presidential election, which occured on November 3rd, 2020. Learn more.

Show:
CompanyYesterday's ClosePrice on November 3rd, 2020Price ChangeConsensus RatingPrice TargetIndicator(s)
Oasis Petroleum logo
OAS
Oasis Petroleum
$39.36$0.11+35,681.8%Hold$1.70Gap Down
Oasis Petroleum logo
OAS
Oasis Petroleum
$39.36$0.11+35,681.8%Hold$1.70Gap Down
WISH
ContextLogic
$24.75$0.20+12,275.0%Buy$25.50Quiet Period Expiration
Gap Down
C3.ai logo
AI
C3.ai
$126.57$2.58+4,805.8%Hold$148.89
BNGO
Bionano Genomics
$9.80$0.50+1,860.0%Buy$4.44
Gevo logo
GEVO
Gevo
$10.51$0.98+972.2%Buy$10.50Analyst Report
EH
EHang
$77.20$8.05+859.0%Buy$14.00Gap Down
Marathon Patent Group logo
MARA
Marathon Patent Group
$18.30$2.10+771.4%Buy$17.00Gap Up
FuelCell Energy logo
FCEL
FuelCell Energy
$18.13$2.15+743.3%Hold$8.83Earnings Announcement
Analyst Revision
Lexicon Pharmaceuticals logo
LXRX
Lexicon Pharmaceuticals
$8.51$1.05+710.5%Hold$8.75Gap Up
Riot Blockchain logo
RIOT
Riot Blockchain
$20.97$3.29+537.4%Buy$7.50Gap Up
GameStop logo
GME
GameStop
$65.01$10.75+504.7%Hold$11.93Analyst Downgrade
News Coverage
Gap Down
3D Systems logo
DDD
3D Systems
$34.48$5.75+499.7%Hold$20.00Analyst Downgrade
Blink Charging logo
BLNK
Blink Charging
$44.35$8.21+440.2%Hold$5.00
SM Energy logo
SM
SM Energy
$8.92$1.78+401.1%Hold$6.03
Westport Fuel Systems logo
WPRT
Westport Fuel Systems
$8.20$1.76+365.9%Buy$9.33Gap Down
Veritone logo
VERI
Veritone
$41.65$8.98+363.8%Buy$16.83Analyst Upgrade
MGNI
Magnite
$40.08$9.24+333.8%Buy$28.50Analyst Downgrade
Analyst Revision
Plug Power logo
PLUG
Plug Power
$66.87$15.47+332.3%Buy$39.09Gap Down
Clean Energy Fuels logo
CLNE
Clean Energy Fuels
$10.57$2.46+329.7%Buy$8.50Gap Down
MicroVision logo
MVIS
MicroVision
$6.76$1.61+319.9%Hold$3.50News Coverage
TIGR
UP Fintech
$17.76$4.35+308.3%N/AGap Down
TIGR
UP Fintech
$17.76$4.35+308.3%N/AGap Down
Amyris logo
AMRS
Amyris
$10.39$2.61+298.1%Buy$7.12Gap Down
HPK
HighPeak Energy
$18.07$4.60+292.8%N/AGap Up
ARVN
Arvinas
$84.09$21.87+284.5%Buy$105.91
Transocean logo
RIG
Transocean
$2.74$0.72+280.6%Hold$2.09
Tellurian logo
TELL
Tellurian
$3.30$0.89+272.8%Hold$3.56Gap Down
STPK
Star Peak Energy Transition
$34.43$9.69+255.3%N/AGap Down
JMIA
Jumia Technologies
$56.96$16.05+254.9%Hold$19.67Analyst Downgrade
MicroStrategy logo
MSTR
MicroStrategy
$577.03$166.57+246.4%Sell$217.50Upcoming Earnings
Gap Up
SI
Silvergate Capital
$76.16$22.50+238.5%Buy$60.00Earnings Announcement
Analyst Report
Analyst Revision
FUTU
Futu
$99.89$29.84+234.8%Buy$17.90Gap Down
FUTU
Futu
$99.89$29.84+234.8%Buy$17.90Gap Down
Celsius logo
CELH
Celsius
$64.68$20.41+216.9%Buy$36.25
BlackBerry logo
BB
BlackBerry
$14.04$4.48+213.4%Hold$6.25Analyst Downgrade
Unusual Options Activity
News Coverage
Gap Down
Appian logo
APPN
Appian
$204.85$65.51+212.7%Hold$71.78
Bloom Energy logo
BE
Bloom Energy
$40.18$12.99+209.3%Hold$28.20
PLTR
Palantir Technologies
$32.58$10.54+209.1%Hold$16.29Analyst Revision
Nordstrom logo
JWN
Nordstrom
$37.37$12.18+206.8%Hold$29.53
Intellia Therapeutics logo
NTLA
Intellia Therapeutics
$74.36$24.32+205.8%Buy$49.04Analyst Revision
Stratasys logo
SSYS
Stratasys
$38.15$12.59+203.0%Hold$20.25
Bilibili logo
BILI
Bilibili
$133.75$44.46+200.8%Buy$45.77Analyst Report
BEAM
Beam Therapeutics
$99.51$34.17+191.2%Buy$33.60
LMND
Lemonade
$153.49$52.96+189.8%Hold$99.40Analyst Revision
SBE
Switchback Energy Acquisition
$39.62$13.71+189.0%Buy
ORGO
Organogenesis
$10.57$3.67+188.0%Buy$11.25
MAXN
Maxeon Solar Technologies
$47.69$16.60+187.3%Hold$33.67Gap Down
BEAM
Beam Therapeutics
$99.51$34.65+187.2%Buy$33.60
Pacific Biosciences of California logo
PACB
Pacific Biosciences of California
$37.42$13.25+182.4%Buy$23.00Insider Selling
Gap Up
SunPower logo
SPWR
SunPower
$47.21$16.85+180.3%Hold$21.33
Stitch Fix logo
SFIX
Stitch Fix
$96.92$34.88+177.9%Hold$38.32
NGA
Northern Genesis Acquisition
$27.15$9.85+175.6%N/A
FUBO
fuboTV
$37.72$13.80+173.3%Buy$41.88Analyst Downgrade
Analyst Revision
FUBO
fuboTV
$37.72$13.80+173.3%Buy$41.88Analyst Downgrade
Analyst Revision
XPEV
XPeng
$56.39$20.72+172.2%Buy$53.87
Tilray logo
TLRY
Tilray
$18.02$6.66+170.6%Hold$12.27Gap Down
GRWG
GrowGeneration
$49.84$18.54+168.8%Buy$44.29
Kosmos Energy logo
KOS
Kosmos Energy
$2.68$1.00+168.2%Hold$2.35News Coverage
APHA
Aphria
$12.92$5.03+156.9%Buy$17.00Gap Down
APHA
Aphria
$12.92$5.03+156.9%Buy$17.00Gap Down
The Children's Place logo
PLCE
The Children's Place
$64.41$25.60+151.6%Hold$37.36
Himax Technologies logo
HIMX
Himax Technologies
$8.69$3.46+151.2%Buy$6.40
eXp World logo
EXPI
eXp World
$102.92$41.53+147.8%Buy$34.50Stock Split
Gap Down
Daqo New Energy logo
DQ
Daqo New Energy
$96.77$39.82+143.0%Buy$38.60
Ballard Power Systems logo
BLDP
Ballard Power Systems
$37.07$15.35+141.5%Buy$31.33Analyst Downgrade
NNOX
Nano-X Imaging
$65.85$27.38+140.5%Buy$67.50
TWST
Twist Bioscience
$190.64$79.37+140.2%Buy$89.00
Ebix logo
EBIX
Ebix
$45.63$19.00+140.2%Buy$54.00News Coverage
BioCryst Pharmaceuticals logo
BCRX
BioCryst Pharmaceuticals
$9.21$3.85+139.5%Buy$9.86
LAC
Lithium Americas
$23.23$9.74+138.5%Buy$17.35Analyst Downgrade
MTS Systems logo
MTSC
MTS Systems
$59.92$25.17+138.1%Hold$31.50Upcoming Earnings
The ODP logo
ODP
The ODP
$47.51$20.18+135.4%Hold$30.50
Cinemark logo
CNK
Cinemark
$19.56$8.32+135.1%Buy$17.31Analyst Report
Gap Down
REZI
Resideo Technologies
$25.06$10.75+133.1%Buy$23.25
Crescent Point Energy logo
CPG
Crescent Point Energy
$3.00$1.29+132.6%Buy$3.22
CCIV
Churchill Capital Corp IV
$22.35$9.63+132.1%N/ANews Coverage
Gap Up
Impinj logo
PI
Impinj
$61.22$26.48+131.2%Buy$46.67Gap Down
Inseego logo
INSG
Inseego
$19.35$8.38+130.9%Buy$12.96
Diamondback Energy logo
FANG
Diamondback Energy
$63.74$27.71+130.0%Buy$62.52Analyst Upgrade
Analyst Revision
Core Laboratories logo
CLB
Core Laboratories
$35.36$15.38+129.9%Hold$21.22Upcoming Earnings
NantKwest logo
NK
NantKwest
$17.25$7.53+129.1%Buy$18.00
INBX
Inhibrx
$36.42$15.96+128.2%Buy$28.67Gap Down
Cardtronics logo
CATM
Cardtronics
$40.86$18.01+126.9%Hold$41.40Analyst Downgrade
News Coverage
Atkore International Group logo
ATKR
Atkore International Group
$48.38$21.46+125.4%Buy$42.00Upcoming Earnings
News Coverage
Aurora Cannabis logo
ACB
Aurora Cannabis
$10.65$4.73+125.2%Hold$12.94Analyst Report
Gap Down
Patterson-UTI Energy logo
PTEN
Patterson-UTI Energy
$6.24$2.78+124.5%Hold$4.03
CRNC
Cerence
$124.71$55.99+122.7%Buy$76.70Insider Selling
Occidental Petroleum logo
OXY
Occidental Petroleum
$21.49$9.65+122.7%Hold$19.12Analyst Revision
Digital Turbine logo
APPS
Digital Turbine
$67.93$30.62+121.8%Buy$47.64
Zai Lab logo
ZLAB
Zai Lab
$181.76$81.94+121.8%Buy$105.67
LSPD
Lightspeed POS
$69.13$31.24+121.3%Buy$72.82
LSPD
Lightspeed POS
$69.13$31.24+121.3%Buy$71.80
Fate Therapeutics logo
FATE
Fate Therapeutics
$97.19$43.94+121.2%Buy$74.50Analyst Report
Precigen logo
PGEN
Precigen
$9.21$4.17+120.9%Buy$11.50
GTH
Genetron
$21.22$9.61+120.8%Buy$19.50
GTH
Genetron
$21.22$9.61+120.8%Buy$19.50
LGVW
Longview Acquisition
$21.33$9.70+119.9%N/ANews Coverage
Gap Down
Upwork logo
UPWK
Upwork
$41.35$18.84+119.5%Buy$33.78
Kohl's logo
KSS
Kohl's
$45.18$20.59+119.4%Hold$32.20
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.
How to invest After a Turbulent 2020 Election

As an investor you know that the market doesn’t really care which party occupies 1600 Pennsylvania Avenue. There’s money to make either way. 

But that doesn’t mean that investors can afford to take a “set it and forget it” approach to their portfolio. Elections have consequences. From tax policy and monetary policy to energy policy there will likely be significant differences in the public policy of the United States. 

On election night, the narrative was that, although Joe Biden was likely to claim the White House, the “Blue Wave” that was being forecast looked to have fizzled out at sea. The basic premise of that still stands (Republicans did gain seats in the House of Representatives). However, investors will still have to wait on the outcome of two senate races in Georgia to have a clear picture of how progressive of an agenda the Biden-Harris administration may be able to push forward.

And the novel coronavirus continues to dominate the headlines. And investors are clearly getting anxious about the pace, and the scope, of lockdown measures throughout the United States and Europe. Yet, the tantalizing promise of one (or more) Covid-19 vaccines is giving the markets a sense of real optimism. 

Things are changing fast, and that’s likely to continue into 2021. Whether you’re an optimist or a pessimist, you should take this time to take a realistic look at your portfolio. With that in mind, let’s take a look at how the election may affect different market sectors.  

Vaccine Stocks Will Remain Volatile

On November 9, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced that the partnership’s Covid-19 vaccine candidate had achieved over 90% effectiveness in its Phase 3 trial. A week later, Moderna (NASDAQ:MRNA) announced a 95% effectiveness rate for its vaccine candidate. And it appears that AstraZeneca (NASDAQ:AZN) and Johnson & Johnson (NYSE:JNJ) may not be far behind.

Does this mean the race is over? Not quite. The Biden administration has stated that “defeating” the virus is its top priority. That means that vaccine stocks are likely to remain the object of investors’ eyes. 

Plus, the devil of the vaccine will be in the details. The Pfizer and Moderna vaccines are based on mRNA technology. I’m not downplaying this. It’s actually really exciting. However, it’s also unproven outside of the clinical trials. Vaccines like Johnson & Johnson are of the more “tried and true” variety that the world is familiar with. But those vaccines have also been rejected by those in the anti-vaccine movement. Maybe it’s time for a different approach? 

The good news is that it appears public opinion is changing. But distributing the vaccine will take some time. And during that time, experts on the subject say there may be many more Covid-19 vaccines. However when considering which vaccine stocks to buy you still need to be selective. Right now, companies like Novavax (NASDAQ:NVAX) and Inovio (NASDAQ:INO), while showcasing interesting approaches, are lagging behind in getting vaccine approvals. This makes them highly speculative, but for the risk tolerant investors they may be worth a small position. 

And what about therapeutics? Even with a vaccine, there will be a need to treat individuals who have acute and life-threatening symptoms. President Trump became the poster child for Regeneron (NASDAQ:REGN). But there are other therapeutic treatments that are in development. Eli Lilly (NYSE:LLY) has already sought out an emergency use authorization for its treatment. And if you’re looking for a dark horse candidate, keep an eye on Humanigen. 

Electric Vehicle Stocks Will Remain Supercharged

If there is one segment of the market that you could say was in a bubble in 2020, it’s been the electric vehicle (EV) sector. Multiple companies have become publicly traded via a special purpose acquisition company (SPAC). This is a perfectly legal way for companies to publicly trade. However, let the buyer beware.

Investors are still trying to digest how seriously to look at the accounting issues with Nikola (NASDAQ:NKLA). And even the companies with pristine (for now) balance sheets, there won’t be products until 2022. That’s a long time for companies to go along without revenue, or profit. 

But that shouldn’t steer you away from the sector. You should however not pay tomorrow’s prices for what the stock may be worth today. Companies like Fisker (NYSE:FSR) and Workhorse (NASDAQ:WKHS) have seen their respective stocks climb and crash

The electric vehicle sector was growing even without the overt endorsement of the Trump administration. With the full-throated support of a Biden administration, you can expect EV stocks to be among the hottest sectors in 2021 and beyond. 

Don’t Let Energy Stocks Wear You Out

Energy stocks came into sharp focus as concerns were raised about what a Biden victory would mean for the energy sector. The knee-jerk reaction is oil stocks down, renewable energy stocks up. The reality will probably be less black-and-white. 

For example, companies like SunPower (NASDAQ:SPWR) surged higher after the election, but corrected when investors digested that a GOP majority in the Senate will likely keep the administration in check. And those that follow the energy sector know that some companies associated with fossil fuels are also helping to lead the renewable energy charge, and have the bandwidth to make change happen.

The bottom line for this sector is that you should stay tuned. A move towards more extreme mitigation techniques to control the virus will likely be a larger catalyst for energy prices in the short term. 

Invest In the Right Tech Stocks

Technology stocks have been extremely volatile this year. After tumbling along with the broader market in March, many tech stocks staged a strong rally. And there was a good reason for that. Staying connected was never more important – whether for remote learning, work-from-anywhere or heightened e-commerce activity. 

And then there’s social media activity. You’ll have to decide for yourself on how you see regulation going. I’m not optimistic but I think the business model for many social media companies is built on shifting sand. 

Some of the areas of tech that I would be looking at are: 5G, cybersecurity, financial technology, artificial intelligence, cloud computing, and even cryptocurrency. These are big picture themes that are likely to capture the market’s attention in 2021

And of course, you can’t ignore a stock like Amazon (NASDAQ:AMZN). However the reality is that Amazon reaches into almost every segment of those key markets.  

The Health Care Sector Needs Clarity

The future of the Affordable Care Act was front-and-center in the 2020 election. And it remains so as the calendar moves closer to 2021. If the law were to be struck down (which would be less likely in a Biden administration), that would be bad news for managed care providers. But there is another concern. If the Democratic party wrests control of the Senate, than significant health care reform is more likely.  And that could spell trouble for private insurers, hospitals, and other affiliated industries. 

On the other hand, telehealth will remain one of the big winners. The pandemic sped up the adoption of an idea that was long overdue. While there is no substitute for the human connection, the ability of patients to connect with doctors about “routine” and even some not-so-routine issues is a big win for patients and doctors alike. 

Companies like Teladoc Health (NYSE:TDOC) are certainly a leader in this space. But you can look for other companies such as One Medical (NASDAQ:ONEM).

If They Build it, Their Stocks Are a Great Buy

Infrastructure stocks surged briefly after the election with the thought that a Biden administration would equate to higher spending on infrastructure. That may still turn out to be the case. However, stocks such as United Rental (NYSE:URI) and Caterpillar (NYSE:CAT) may struggle in the coming months particularly if businesses remain shut down. As in the summer, you could expect these companies to bounce back rather quickly, but this is certainly a segment to be looking at as a long-term buy. 

And speaking of building things, another sector that is likely to remain strong in 2021 will be homebuilder stocks. The Federal Reserve is going to keep interest rates at a level near 0%. That means mortgage rates will be attractive. And many homeowners are deciding that their urban apartment is no place to work – or live - remotely.  

Estimates came out this week saying it may not be until 2025 for New York City to get back to pre-coronavirus levels of economic activity. And already approximately 300,000 residents have fled the city. No matter how you look at it, there’s an urban flight, but people will still need places to live. 

Travel Stocks Remain The Elephant In the Room

The narrative on travel stocks remains the same. There is pent-up demand for travel and once passengers get the all-clear via a vaccine, business will come back to normal. But that is going to lead to difficult questions. For example, according to Dr. Felicity Nicholson, lead doctor at Trailfinders Travel Clinic in the United Kingdom, specific destinations may require passengers to carry proof of vaccination. Many businesses are realizing that (some) business travel can be handled virtually. What percentage of that will come back is impossible to say. And even if it does come back, what percentage of workers will be comfortable traveling and/or getting the vaccine? 

Overall, I believe our desire to travel is stronger than our hesitancy to get a vaccine I’m bullish on the long-term growth in the sector, but many travel stocks are no longer oversold. That means investors may have to wait on another dip before diving in. 

The Final Word on Investing In a Post-Election World

I suppose my final work is to say that the final chapter has yet to be written. In fact, it’s fair to say that investors are only at the beginning of what promises to be a long story that may play out over several years. 

The overly simplistic answer is that the economy will simply return to normal once the majority of Americans are vaccinated. The truth is far more complicated. There has been damage done to the economy. Businesses that were thriving are now closed for good. Millions of Americans are out of work. And yes, that number is down dramatically. But many businesses are not going to be inclined to hire workers without clearly understanding the tax ramifications for their business. 

I’ve long been a bullish investor and I believe that stocks are the right place to be for the vast majority of investors. However, the market is not likely to enjoy the extreme attention it received from the Trump administration. Simply put, many stocks may be allowed to fail. And that means that you have to take action now to make sure the stocks you are investing in have a story that still holds up.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.